Al-Daghri Nasser M, Wani Kaiser, AlHarthi Hind, Alghamdi Amani, Alnaami Abdullah M, Yakout Sobhy M
Biochemistry Department, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Chair for Biomarkers of Chronic Diseases, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
J Clin Med. 2021 Jul 26;10(15):3288. doi: 10.3390/jcm10153288.
Recently, inflammasomes such as NLRP3 as cytosolic pattern-recognition receptors have been implicated in the development of inflammation; however, limited investigations report the circulating levels of this protein. The objective, thus, was to investigative circulating NLRP3 levels in Saudi patients with a low-grade inflammatory disorder called metabolic syndrome (MetS). Two hundred Saudi adults aged 30-65, with or without MetS diagnosed on the basis of National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) criteria, were randomly recruited. Five MetS components were established according to the diagnostic criteria in the study subjects. Circulating levels of NLRP3 and known inflammation markers, such as tumor necrosis factor α (TNF-α), C-reactive protein (CRP) and interleukins (IL-1β and IL-18), were measured in the blood samples taken from the study subjects. Gender-based analysis showed a significant elevated circulating levels of NLRP3 in non-MetS men compared to non-MetS females ( < 0.001). Moreover, an increase in circulating levels of NLRP3 with a number of MetS components ( = 0.038) was observed only in females. A significant positive correlation of NLRP3 levels with age (r = 0.20, = 0.04), BMI (r = 0.32, < 0.01) and waist (r = 0.24, = 0.02) and a significant negative correlation between NLRP3 and HDL-cholesterol (r= -0.21, = 0.03) were also observed in females. Logistic regression analysis also yielded a sex-specific positive association of NLRP3 with MetS in females, with this association influenced mostly by central obesity and dyslipidemia components of MetS. In conclusion, this study suggests a sexual disparity in the circulating levels of NLRP3, with a trend of increasing circulating NLRP3 levels with increasing MetS components observed only in females, influenced mostly by adiposity and dyslipidemia components of MetS. Longitudinal studies with a larger sample size and investigating sex-specific hormones with NLRP3 would be needed to establish a causal relationship of NLRP3 with MetS.
最近,诸如NLRP3这类作为胞质模式识别受体的炎性小体与炎症的发生发展有关;然而,关于这种蛋白循环水平的研究报道有限。因此,本研究旨在调查患有一种名为代谢综合征(MetS)的低度炎症性疾病的沙特患者的循环NLRP3水平。随机招募了200名年龄在30 - 65岁之间、根据美国国家胆固醇教育计划成人治疗小组第三次报告(NCEP ATP III)标准诊断为患有或未患有MetS的沙特成年人。根据研究对象的诊断标准确定了五项MetS组分。在采集自研究对象的血液样本中检测了NLRP3以及已知炎症标志物如肿瘤坏死因子α(TNF-α)、C反应蛋白(CRP)和白细胞介素(IL-1β和IL-18)的循环水平。基于性别的分析显示,与未患MetS的女性相比,未患MetS的男性中NLRP3的循环水平显著升高(<0.001)。此外,仅在女性中观察到NLRP3的循环水平随MetS组分数量的增加而升高(=0.038)。在女性中还观察到NLRP3水平与年龄(r = 0.20,= 0.04)、体重指数(BMI)(r = 0.32,<0.01)和腰围(r = 0.24,= 0.02)呈显著正相关,与高密度脂蛋白胆固醇呈显著负相关(r = -0.21,= 0.03)。逻辑回归分析还得出,在女性中NLRP3与MetS存在性别特异性正相关,这种相关性主要受MetS的中心性肥胖和血脂异常组分影响。总之,本研究表明NLRP3的循环水平存在性别差异,仅在女性中观察到循环NLRP3水平随MetS组分增加而升高的趋势,这主要受MetS的肥胖和血脂异常组分影响。需要进行更大样本量的纵向研究并研究NLRP3与性别特异性激素的关系,以确立NLRP3与MetS之间的因果关系。